{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/769068598",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/85074116"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#769068598",
  "code": "4A01.05",
  "source": "http://id.who.int/icd/entity/769068598",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome due to CD40 ligand deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/259869879",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1616506198/other"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome due to CD40 deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/1381161550",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1616506198/other"
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Immunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of B-cells"
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Immunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of B-cells"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper IgM"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Activation-induced cytidine deaminase deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/603312357"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome type 2"
      },
      "foundationReference": "http://id.who.int/icd/entity/603312357"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome due to AID deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/603312357"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome due to AICDA deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/603312357"
    },
    {
      "label": {
        "@language": "en",
        "@value": "HIGM2 - [hyper-IgM syndrome type 2]"
      },
      "foundationReference": "http://id.who.int/icd/entity/603312357"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome due to uracil N glycosylase"
      },
      "foundationReference": "http://id.who.int/icd/entity/492472329"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome type 5"
      },
      "foundationReference": "http://id.who.int/icd/entity/492472329"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hyper-IgM syndrome due to UNG - [uracil N glycosylase] deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/492472329"
    },
    {
      "label": {
        "@language": "en",
        "@value": "HIGM5 - [hyper-IgM syndrome type 5]"
      },
      "foundationReference": "http://id.who.int/icd/entity/492472329"
    }
  ]
}